BRAIN Biotech Aktie

BRAIN Biotech für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: 520394 / ISIN: DE0005203947

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>
09.09.2026 02:30:00

The EV Brain Drain: Lucid Is Bleeding Talent While Rivian Is Evolving

Key executive departures of public companies, especially young companies, can raise a number of red flags and problems. Some CEO departures can cause the stock price to drop immediately, but even lower level executive departures can cause ongoing projects to stall, take with them years of industry experience, client relationships, as well as in-house know-how. Numerous departures can lower morale or signal hidden financial problems, board fights, or worse. That sets the context to explain to investors why Rivian's (NASDAQ: RIVN) recent CFO departure is more evolution (more on this in a second) compared to Lucid's (NASDAQ: LCID) that signals deeper trouble.

Let's first look at Rivian's recent departure: CFO Claire McDonough is stepping down at the end of October after nearly six years to become the CFO of GE Vernova. At first glance, this could raise investors' eyebrows as the company is currently at the most important point in Rivian's young history: the R2 production ramp. That said, it's really more of an evolution.

Image source: Rivian.

Continue reading

Analysen zu BRAIN Biotech AG

mehr Analysen
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BRAIN Biotech AG 2,91 3,56% BRAIN Biotech AG